Drugs / Carotegrast methyl
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06897150 | Jun 2022 → Mar 2025 | ulcerative colitis | Takayuki Yamamoto | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Carotegrast methyl | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06897150 ↗ |
| Action | Inhibit | “α4-integrin inhibitor” NCT06897150 ↗ |
| Route | Oral | “oral” NCT06897150 ↗ |